Following weeks of good news about diminishing case counts, CDC Director Rochelle P. Walensky, MD, MPH, said in a White House press briefing in early March that the country had actually recorded an increase in COVID-19 cases over the past weeks.
Walensky warned that declines in case counts and hospital admissions “may be stalling, potentially leveling off at still a very high number.”
“We at CDC consider this a very concerning shift in the trajectory,” she said.
Source: Healio
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more
